Efficacy and Safety of Filgotinib as Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the Phase 2b/3 SELECTION Study

Authors :: R Koch
L Peyrin-Biroulet
EV Loftus
S Danese
S Vermeire
WJ Sandborn
R Fogel
S Nijhawan
R Kempinski
R Filip
I Hospodarskyy
J McNally
C Yun
S Zhao
X Liu
C Tasset
R Besuyen
M Watanabe
S Schreiber
G Rogler
T Hibi
BG Feagan
Source :: Zeitschrift für Gastroenterologie.
Publication Year :: 2021
Publisher :: Georg Thieme Verlag KG, 2021.

Subjects :: medicine.medical_specialty
Filgotinib
Maintenance therapy
business.industry
Internal medicine
medicine
medicine.disease
business
Gastroenterology
Ulcerative colitis
Selection (genetic algorithm)

Full Text Access

Tools